viewBushveld Minerals Limited

Investor Update: hVIVO’s mosquito vaccine moves into the clinic

Headlines from the Proactive Investors UK newsroom. 

Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as Zika and Malaria.

Bushveld Minerals (LON:BMN) remains on track to meet current 2019 production guidance of 2,800 to 2,900 metric tonnes of vanadium. Productivity improvements boosted output in the second quarter by 14% compared to the previous three months.

Immotion (LON:IMMO) has raised £370,000 more from its fund raise yesterday after an over-subscription broker option was exercised. In total, the virtual reality group raised £2.37mln from the option and placing.

Impairments and a weak UK  economy meant Lloyds interim profits and interest income fell in the first half year to June.

Clothes retailer Next has raised its profit forecasts for this year after a strong performance all through May, June and July. Sales in the quarter rose by 3.8%

Takeaway app group Just Eat’s profits slumped by 98% after heavy investment in its delivery service and food.

Quick facts: Bushveld Minerals Limited

Price: 22.8 GBX

Market: LSE
Market Cap: £2.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bushveld Minerals Limited named herein, including the promotion by the Company of Bushveld Minerals Limited in any Content on the Site, the...



Investor Update: Endorsement for Angle's liquid biopsy system Parsortix

Top stories from the Proactive Investors UK newsroom. Angle (LON:AGL) has received an endorsement for its liquid biopsy system Parsortix from European cancer centre UKE, which says it has potential as a biomarker to test for lung cancer. Security group Westminster (LON:WSG) has signed...

on 21/6/19

2 min read